Overall Survival, Costs, and Healthcare Resource Use by Line of Therapy in Medicare Patients With Newly Diagnosed Metastatic Urothelial Carcinoma

Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1591424
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Informa UK Limited


Related search